# Empowering Through Education

> **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637)
> **Publisher:** CED Clinic (https://cedclinic.com)
> **Canonical URL:** https://cedclinic.com/testimonial/empowering-through-education/
> **Published:** 2024-12-12T09:29:37-04:00 | **Last Modified / Clinically Audited:** 2025-01-09T17:44:31-04:00
> **Clinical Summary:** Dr. Caplan helped me navigate postpartum anxiety with a science-based, empowering approach that transformed my outlook on health.

---

“As a mother of two, I was cautious about trying medical cannabis for postpartum anxiety, but Dr. Caplan quickly put my fears at ease. He offered a science-backed approach that felt safe and sensible, walking me through each step with empathy and care. His book was also an invaluable tool—it gave me the confidence to understand how to approach treatment without guesswork. Now, I feel like I’m thriving instead of just surviving. I’m so grateful for Dr. Caplan’s guidance and for the way he made this process feel not only accessible but also empowering.”

**Olivia G**

 

### Related

---

### Verification & Medical Governance

- **Lead Clinical Author:** Benjamin Caplan, MD
- **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House).
- **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`).
- **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/).
- **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637).
- **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).